Klinikai vizsgálatok Nct
Clinical Trial Results:
An Open-label, Randomized, Phase 3 Trial of intravenous Temsirolimus (CCI-779) at two Dose Levels Compared to Investigator's Choice Therapy in relapsed, Refractory Subjects with Mantle Cell lymphoma (MCL)
| Summary | |
EudraCT number | 2004-001430-16 |
Trial protocol | AT SE GB DE IT ES |
Global completion date | 04 Jan 2011 |
| Paediatric regulatory details | |
Is the trial part of an agreed EMA paediatric investigation plan? | No |
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | No |
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | No |
| Results information | |
Results version number | v1(current) |
This version publication date | 21 Mar 2016 |
First version publication date | 11 Feb 2015 |
Other versions | |
Summary report(s) | 3066K1-305 EU Posting |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03 for further information.